Key Dates

Related Announcements

• January 17, 2024 - High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional).  See NOFO RFA-DA-25-060 

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

This Notice is to inform potential applicants that the HIV Research Program at the National Institute on Drug Abuse (NIDA) will host a pre-application webinar on Tuesday, April 30, 2024, from 11:00 a.m. to 12:30 p.m. (Eastern Daylight Time, EDT) for those interested in learning more about RFA-DA-25-060 High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional) initiative. Program and Review Staff from NIDA will be available to highlight the key features of the RFA-DA-25-060 initiative and to answer questions from prospective applicants. Details on how to attend and submit questions will soon be available on the HIV Research Program Meetings of Interest.

Participation in the webinar is not required to submit an application. We plan to post a recording of the session on the HIV Research Program Meetings of Interest within two weeks after the webinar.

Inquiries

Please direct all inquiries to:

Vasundhara Varthakavi, DVM, PhD
National Institute on Drug Abuse (NIDA)
Phone: 301-443-2146
Email: vasundhara.varthakavi@nih.gov

Richard A. Jenkins, PhD
National Institute on Drug Abuse (NIDA)
Phone: 301-443-1923
Email: jenkinsri@nida.nih.gov

Kathleen Borgmann, Ph D 
National Institute on Drug Abuse (NIDA)
Phone: 301-594-6561
Email: kathleen.borgmann@nih.gov

Raul N. Mandler, MD, FAAN, FANA
National Institute on Drug Abuse (NIDA)
Phone: 301-480-2541 
Email: mandlerr@mail.nih.gov